Health Archive » October, 2017

Health - October, 2017

341 articles

• Investor Tells Of Cash-Out Woes In Trial Of Ex-Katten Atty
• Walgreens Hit With Suit Over Prescription That Killed Child
• Menendez Jury Instructions Crafted With Eye On McDonnell
• CVS Says Spat Over Flu Shot Calls Shouldn't Be Reassigned
• Valeant Pays $13M To End Diabetes Drug Royalty Claims
• Patient Sues Texas Hospital Over Brain Injury From Fall
• 4th Circ. Finds Medical Necessity Material To Health Fraud
• CEO Accused Of Tipping Off Ex-MLBer Fights New Charges
• 9th Circ. Backs Appellate Attys' Fees For Benefit Plan
• Drugmakers Want Chicago's Opioid Suit Paused Pending MDL
• Insys Founder Resigns From Board After Opioid Charges
• 9th Circ. Revives Suit Over Blue Cross Plan Vagueness
• J&J Unit Hit With Trimmed FCA Suit Over Hip Implants
• NJ Sues Purdue Pharma Over Opioid Marketing
• Cerner Asks 9th Circ. To Revive Bid To Enforce $63M Award
• REIT Makes $69M SoCal Expansion With Nursing Portfolio
• Judging A Book: McConnell Reviews 'Unequal'
• Fla. Doc Must Pay $16M To Amputee Over Delayed Treatment
• CareFirst Pushes High Court To Tackle Breach Standing Divide
• J&J Toxicologist Defends Brand's Talc In Mesothelioma Trial
• Retrophin Privilege Fray Irks Judge At Ex-Katten Atty's Trial
• Chemed To Pay $75M In Largest-Ever Hospice FCA Settlement
• Health Care Fraudster Gets 2.5 Years For Role In $175M Plot
• Menendez, Doctor Lose Mistrial Bid Over Excluded Evidence
• Catholic Health System Pays $6M To Settle Rehab FCA Suit
• Ex-Humana Worker Denied Collective Cert. In OT Suit
• Feds Must Pay $22M To Native Alaskan Paralyzed By Stroke
• Gov't Health Center Accused Of Biopsy Chemical Mix-Up
• Health Records Co. 'Not Qualified' To Protest $9B VA Contract
• Surgeon Picks Bone With J&J's DePuy Over Spinal Device
• Ex-Federal Prosecutor, Dechert Atty Joins Saul Ewing In Philly
• Congressional Forecast: November
• NPR Station Can Get Meningitis Juror Names, But Must Wait
• Fla. Judge Can't Clarify That Ruling Voids Nursing Home Rule
• Md. Hospital Quotes Shakespeare In Defense Of Phony Doctor
• Making Pro Bono Work
• Being There: Preparing Witnesses For Depositions
• 5 Ongoing Collective Bargaining And Organizing Challenges
• A Common-Sense Approach To Conversion In Digital Age
• Trump Admin Eyes Looser Limits On ACA Essential Benefits
• Robbins Geller To Lead Consolidated Envision Investor Suit
• FCA Decision Tracker: Continued Interpretations Of Escobar
• Last Member Of $374M Medicare Fraud Plot Gets 10 Years
• Judge Bars Emergency Rules On Nursing Home Generators
• Stanford's $8M Clinical Worker OT Deal Stalls On PAGA Cut
• 2 Alabama Abortion Laws Deemed Unconstitutional
• Making Pro Bono Work: The Sidley-Exelon Partnership
• NY Hospitals Must Face Stroke Patient's Med Mal Suit
• Australian Antitrust Body Won't Fight Essilor-Luxottica Deal
• Taxation With Representation: Cooley, Alston, Mayer, Davis
• Recipe For Legal Project Management: Look To BBQ Champs
• Zenefits, Co-Founder To Pay SEC $1M Over Misled Investors
• J&J Talc Caused Woman's Mesothelioma, Expert Tells Jury
• Menendez Lawyers Want Mistrial Over Excluded Evidence
• Health Co. Founders Say Magellan Deal Will Cost Them $10M
• Eager To Run, Fla. Medical Marijuana Industry Crawls Forward
• Ambulance Cos. Can't Escape $20M FCA Kickback Suit
• Medco Dodges 4th Version Of Drug Fraud FCA Suit
• Ropes & Gray DQ'd In Guardant Health's False Ad Suit
• Trump Declares Opioid Emergency, Critics Call For Funding
• Stryker's 'Intrusive' Hip Implant Patient Survey Rejected
• Deals Rumor Mill: CVS, Weinstein Co., Evoqua Water Tech
• 'Impeccable' $295M Deal In Stericycle MDL Gets Initial OK
• Investor Sues Dialysis Co. Execs Over Insurance Billing Tactic
• With New Scrutiny, Life Sci Startups Become Risky Targets
• Insys Founder Charged With Racketeering In Opioid Scheme
• Darrow Everett, Jeffrey Zwick Guide $48M Nursing Home Loan
• Xytex Settles Claims Over Poorly Screened Sperm Donor
• Making Pro Bono Work: Can You Practice In Your State?
• 'KRACK' Wi-Fi Flaw: What Health Care Cos. Should Know
• Representing Women At The Intersection Of Law And Finance
• Retrophin Ex-Chairman Says Ex-Katten Atty Not Independent
• Menendez Aide Pressed On Exception To Gifts Disclosure
• Purdue Faces US Probe Over OxyContin Marketing
• RI Doc Admits To Health Fraud, Opioid Kickback Scheme
• Second Pharmacist Convicted In Meningitis Outbreak Trial
• Deals Rumor Mill: Pfizer, Deutsche AM, Learning Care Group
• NY Doc Convicted Of Taking Bribes In Test-Referral Scheme
• NJ Hospital Loses Medicaid Reimbursement Rate Appeal
• Maryland Hospital Sued By Patients Of Phony OB-GYN
• Immigrant Abortion Dispute Closed, But ACLU Vows Vigilance
• Trump Admin Need Not Pay ACA Subsidies, Judge Rules
• Recent Disasters Highlight Drug Shortage Problem
• Making Pro Bono Work: Building Sponsorship Relationships
• Real Estate Rumors: Pinnacle, Montecito Medical, BBX
• House Bill Would Raise Stakes Of Congressional Inquiries
• Tension Between Legal Marijuana Use And Employer Rights
• Trending In Telehealth: Behavioral Health Services
• What I Learned In My 1st Year: Be A Sponge
• Menendez Talk Didn't Cause PAC Donation Push, NJ Atty Says
• J&J Talc User's Body Had Asbestos In It, Jury Hears
• Ex-Katten Atty Seeks To Chase Shkreli's Specter From Trial
• Delta Hit With $1.3M Verdict For HIV-Motivated Firing
• Deals Rumor Mill: Unilever, Siemens, Air Berlin
• Pharma Cos., States Battle Over Opioid Litigation Transfer
• Jury Hints At Racketeering Conviction In Meningitis Case
• Hatch, GOP Rep. Float ACA Deal With Renewed Subsidies
• CliniComp Looks To Revive Protest Of VA Health Records Deal
• Making Pro Bono Work: Beyond The Hurdles
• DC Circ. Paves The Way For Immigrant Teen's Abortion
• Md. VA Facility's Opioid Treatment Lacking, Report Says
• 11th Circ. Just Got More Attractive For Business Bankruptcy
• J&J Wins Battle Against $417M Talc Award, But War Not Over
• Ex-Katten Atty Was Shkreli's Right-Hand Man, Jury Hears
• Albertson Nears OK For $1.6M Pharmacist Meal Break Deal
• Health Co. Slams Discovery Ruling In Med Mal Murder Case
• Trump's ACA Requests Signal Doubt On Regulatory Powers
• Fla. High Court Won't Take Up Health Records Fee Case
• Judge Slams State Efforts To Block Trump's ACA Subsidy Cut
• Ex-State Dept. Official Denies That Menendez Made Threat
• Fla. Woman Gets More Than 4 Years For Medicaid Fraud
• Aetna Mailing Breached Privacy, HIV Patient Says
• Health Staffing Co. Sanctioned Over Payroll Doc Destruction
• Doctors' Counsel Nab $27M In Sanofi Vaccine Antitrust Row
• Judging A Book: Pryor Reviews 'Scalia Speaks'
• 8th Circ. Won't Rehear UnitedHealth's $350M Insurance Feud
• Blue Wolf Brings In $540M For Latest PE Fund
• Arbitration Agreements And FCA: Lessons From 9th Circ.
• The Inside Counsel Revolution
• J&J Wins Toss Of $417M Talc Cancer Verdict In Calif.
• DC Circ. Puts Immigrant Teen's Abortion On Hold, For Now
• If J&J Talc Had Asbestos, It Could Cause Cancer, Expert Says
• Opioid Litigation Roundup: An Overview Of Major Cases
• Trump Admin Fights Dem AGs' Bid To Restore ACA Subsidies
• Ex-Katten Atty Betrayed Client, Feds Say As Trial Starts
• Meningitis Outbreak Murder Trial Sent To Jury
• Texas Justices Refuse UT Clinic's Immunity Bid In Death Suit
• HHS Looks To Dodge $1.5B Pharmacy Antitrust Suit
• Mass. Hospital Double-Booked Surgeries, Whistleblower Says
• Patriarch Partners Calls TransCare Doc Request Too Broad
• Dems Float Bills To Roll Back HHS' Birth Control Exemptions
• How Arbitrators Maintain Proportionality In Discovery
• Ex-Pharmacist In NECC Meningitis Case Puts Blame On Boss
• Benefits Co. Rips Injunction Bid In $1.5B Antitrust Suit
• Menendez Defense Challenges Claim Of Threatening Hearing
• Bipartisan Health Care Bill Gets More Senate Support
• NJ Wants To Yank Doc's License For Overprescribing Opioids
• Ex-Katten Atty's Jury Won't Hear Of Shkreli Acquittal
• Dallas ERs Want Google To Turn Over Online Reviewer IDs
• J&J's Talc Bore Harmful Asbestos, Calif. Retrial Jury Told
• Ariz. High Court Rules On Inadequate Med Mal Witnesses
• Fla. Appeals Court Upholds Nursing Home Generator Rule
• Fla. Doctor Faces Health Care Fraud, Obstruction Charges
• Texas Nursing Home Settles Negligent Care Claim For $5M
• Gov't To Face ACLU At DC Circ. On Immigrant Teen's Abortion
• Military Bases Didn't Report Water Systems Issues, GAO Finds
• The Revolution Of Employer-Sponsored Health Insurance
• The Law Firm CFO's Role In The Strategic Planning Process
• Judge Hesitant To Rubber-Stamp Aegerion's $36M Fraud Deal
• Menendez 'Not Angry' Over Medicare Policy, Ex-Staffer Says
• NPR Station Wants Names, Addresses Of Meningitis Jurors
• UnitedHealthcare Seeks Defeat Of Medicare Overpay Rule
• Race Bias Treaty Doesn't Preempt Title VII, 9th Circ. Says
• 4 Tips For Flu Shot Programs That Won't Get You Sued
• Nursing Home Workers Claim Fingerprint Scans Violate Law
• Wider Liability At Stake In Hepatitis Row, Pa. Justices Told
• Atty, CEO Plead Guilty Over $86M Pump-And-Dump Scheme
• Trump Downplays Support Of Bipartisan Health Care Deal
• Chicago Seeks Janssen Employees' Info In Opioid Suit
• Workers Say Lincare Exposed Their Data In Phishing Email
• $12B Medicaid Procurement Flawed, Pa. Appeals Court Hears
• Ex-NJ Health Care Leader Joins Porzio Bromberg
• 11th Circ. Clears Fla. Medical Practice In Pregnancy Bias Suit
• Law Firms Must Transition To An Industry Sector Approach
• 5th Circ. Backs Miss. Medical Center's Win In Bias Suit
• Ohio Court Backs Medical Board's Denial Of Doc's License
• Stericycle Agrees To $295M Deal In Overcharging MDL
• Crist Visit To Menendez Doc Used To Counter Bribery Charges
• J&J Wins Mo. Appeal Of $72M Talc Cancer Verdict
• Shkreli Acquittal Inadmissible At Trial, Gov't Argues
• McKesson Fax Recipients Urge 9th Circ. To Revive Cert. Bid
• Sens. Scrutinize Murky Drug Pricing, Rebate Deals
• Boss Pushed Pharmacist To Step Up Testing Before Outbreak
• More Medicare Patients Join Class In Due Process Suit
• NJ Doctor Cops To Bilking Medicare, Others Out Of $3M
• FDA Warning Wire: Multiple Issues At Dialysis Co.
• Cohen Milstein Forfeited Fees For Exiting Suit, Court Told
• J&J Asbestos Trial A New Front In Talc Litigation
• 11th Circ. Revives Prisoner's Suit Over Hep C Treatment
• Judging A Book: Kozinski Reviews 'The Judge'
• Bipartisan ACA Deal Would Renew Subsidies, Add Flexibility
• Sen. Wants Repeal Of Opioid Law That Sunk Drug Czar Pick
• Rep. Who Cut DEA Powers Out As Trump's Drug Czar Pick
• The Rise Of Employee Religious Discrimination Claims
• Agents' Vague Answers Mixed Bag For Defense In $1B Fraud
• Self-Effacing Judge Asks For Road Map In UnitedHealth Trial
• Theory Behind Menendez Charges Ruled OK Under McDonnell
• HCA Healthcare Must Face Calif. Doctor's Retaliation Suit
• Excess Insurer Must Face $4M Data Breach Coverage Suit
• High Court Rejects Trio Of Employment Cases
• Ex-Katten Atty Loses Bid To Nix Shkreli Conspiracy Charge
• BP Midstream, Four Others Launch IPOs Exceeding $1.3B
• 21st Century Oncology Cleared To Solicit Ch. 11 Plan Votes
• Gov't Scientists Tell Of Rare Outbreak As Trial Nears End
• Pa. Med Board Erred In Nixing License Reinstatement: Court
• Mo. High Court Pauses J&J Talc Cancer Trial Over Venue Row
• Class Seeks Final OK On $98.3M Bon Secours ERISA Deal
• Fresenius Can't Duck FCA Claims Over Hepatitis B Tests
• PharMerica Says FCA Whistleblowers Got Info Secondhand
• Evolution Of A Crisis: Opioid Claims Pick Up Speed
• New Post-Recession Metrics For BigLaw Partner Success
• DOJ Drops Medicare Advantage Suit Against UnitedHealth
• 19 AGs Sue Trump Over Halted ACA Subsidies
• Cigna Tells 11th Circ. 'Interloper' Is 'Looting' $25M Deal
• Brand Battles: CVS, Adidas, Monster Energy, Amazon
• Patent Litigator Goes After Wearables For Seniors
• Fla. Denied Bid To Remove Judge In Medical Pot License Suit
• 9th Circ. Judge Balks At Blue Shield Customers' Cert. Bid
• Trump Executive Actions Make Short-Term ACA Deal Likely
• Texas Man Arrested In $25M Health Care Fraud Scheme
• Time To Lift Student Loan Counseling Restrictions
• Pa. Health Dept. Asks Court To Uproot Medical Pot Permit Suit
• Health Hires: Boston Scientific, Mintz Levin
• Trump Axes Crucial ACA Cost-Sharing Subsidies
• Campbell-Ewald Cuts Need For Class Cert. Bid In TCPA Row
• J&J Cites Jury Misconduct In Bid To Nix $417M Talc Verdict
• Fla. Nursing Home Generator Rule May Be Untenable, For Now
• What To Expect As BigLaw Vet Eric Hargan Runs HHS
• UT Docs' Employee Status At Issue Before Texas High Court
• Litigators Wanted. Will Pay Top Dollar.
• Del. Judge OKs Limits On Access To Hospital Chain Books
• TCPA Exempts Charity Fundraiser's Calls, Illinois Judge Says
• 7th Circ. Won't Revive Payors' Depakote Suit Against Abbott
• CMS Asks 1st Circ. To Undo Hospital Reimbursement Ruling
• 7th Circ. Won't Grant Cert. To Union Fee Challengers
• Morgan Stanley PE Arm Raises $275M For North Haven Fund
• 1st Circ. Won't Rethink Ending Sarepta Securities Suit
• How Conduct Abroad Impacts Health Care Business In US
• Trump Loosens Insurance Rules In Bid To Weaken ACA
• NJ Judge Challenges Theory Under Menendez Bribery Trial
• Patients Fault Cancer Center Over Ch. 11 Plan Info Omissions
• Philips, DOJ Reach Deal Over Defibrillator Missteps
• Hospital Can't Pause TCPA Suit For Autodial Definition
• Mich. Tribe Wants More From Blue Cross In Hidden Fees Suit
• Texas Justices Question Med Mal Suit Nix Over 'Technicality'
• Why You Should Consider Hyperlinking Your Next Brief
• NJ Justices Question Nurse's Silence In Unemployment Row
• FDA Expert Testifies Of Unparalleled Contamination At NECC
• Missouri Hospital Gets Doc's Whistleblower Trial Win Nixed
• Buchanan Ingersoll Hires Kirkland Pharmaceuticals Litigator
• Insights On Protecting Referral Sources With Noncompetes
• Trump Taps Greenberg Traurig Vet As Acting HHS Chief
• Menendez Advocacy Fell Between PAC Donations, Agent Says
• Ex-Katten Muchin Atty, Prosecutors Submit Revised Juror Q's
• 3 Meningitis Pharmacy Workers Must Face FDA Fraud Claims
• FDA Warning Wire: Bush's Baked Beans, Univ. Of Michigan
• Asian-Americans Facing Challenges In The Legal Industry
• Bear Stearns Seeks 3rd Circ. Halt To FINRA Claim's Arbitration
• NLRB Clears Nonunion Hiring Rule After 1st Circ. Flip
• Pa. Panel Shields Insurers' Rates From Records Request
• Mass. AG Runs Point As Top Trump Critic
• Express Scripts To Pay $3.6B For PE-Backed EviCore
• Mistrial Declared In Case Alleging Asbestos In J&J Talcum
• Good And Bad News For Massachusetts Life Sci, Health Cos.
• Asbestos In J&J's Talc Caused Woman's Illness, Jury Told
• MDL May Be On The Horizon In Opioid Litigation
• Insurers Stiffed Chiropractors On Injury Claims, Suits Say
• Judge Unlikely To Dismiss Ex-Katten Atty Conspiracy Count
• 6th Circ. Nixes Health Provider's Retaliation Suit
• Pharma Employee Admits To Health Care Benefits Fraud
• Pharmacist In Meningitis Trial Ignored Drug Recipe, Jury Told
• A BigLaw Ladies' Guide To Becoming A 1st-Chair Trial Lawyer
• St. Joseph's Nurses Get Initial OK For $42M ERISA Deal
• Insurer Must Cover Autism Services In School: Pa. Justices
• BALCA Rejects Labor Cert. For Personal Care Aides In Fla.
• Texas Neurosurgeon's Suit Over Hospital Suspension Tossed
• Aetna Suit Over HIV Drug Disclosures Lands In Pa.
• Trump Admin Sued Over Contraception Mandate Exemptions
• FCA Suit Against Alere Unsealed After US Passes On Case
• UnitedHealth Beats DOJ's Medicare Advantage FCA Suit
• Gov't Backs Strict FCA First-To-File Bar In Allergan Case
• Feds Re-Up Bid To Ban 5 Experts In Ex-Katten Atty's Trial
• Meningitis Pharmacist Brushed Off Concerns, Colleague Says
• NJ Sues Insys Over Opioid Drug Push, Calls Conduct 'Evil'
• Allstate Can Arbitrate NJ Auto Injury Action After All
• Jilted Pa. Medical Marijuana Bidder Drops License Challenge
• IRS Can't Fight Facts In Transfer Pricing Suit, Medtronic Says
• TransCare Trustee Wants More Docs From Patriarch Partners
• Novartis, Genentech Again Beat Xolair Kickback Suit
• DOJ Says Transgender Ban 'Not Ripe' For Court Challenge
• PharMerica Must Face State FCA Claims, Whistleblowers Say
• LA County Can't Escape Home Health Care Workers' OT Suit
• Insurer Aims To Trim Chiropractic Med Mal Coverage Demand
• Insys To Pay $500K To End Mass. Opioid Marketing Claims
• Dallas Lab Calls UnitedHealth's $100M Fraud Suit 'Shakedown'
• Ogletree Deakins Boosts Presence In West With 3 Attys
• 6 Charged In Florida Chiropractic Insurance Fraud Scheme
• J&J, DePuy Lose Bid To Pause FCA Ruling At 1st Circ.
• The New HHS Approach To HIPAA?
• 5 Tips To Ensure Proper Deposition Behavior
• NJ Atty Sent Doctor's Donations For Menendez, Witness Says
• HCA Hospitals To Pay $8.6M Over Ambulance Co. Kickbacks
• BMC, Tufts Secure MassHealth Contracts Worth $1B Per Year
• Surgery Centers Ask 9th Circ. To DQ Judge From Billing Suit
• Calif. Appeals Court Revives Snoring Aid Class Action
• Med Building Developer Sues Ex-Prez Over Bonus Claims
• Irma Could Trigger Uptick In Nursing Home Claims
• Greenberg Traurig Vet Gets Senate Nod For HHS Deputy
• 2nd Circ. Nixes Harleysville Coverage In Injury Suit
• How Bankruptcy Can Maximize Health Care Businesses' Value
• Allergy Care Antitrust Case Headed Toward Trial
• AbbVie, Lilly Slam Discovery Bid In Testosterone MDL
• Retirees Lose Class Cert. Bid Over Health Benefit Changes
• Pa. Pharmacy To Pay $2.67M To Resolve FCA Allegations
• The Future Of Value-Based Care After Repeal And Replace
• ACLU Sues FDA Over Access Restrictions To Abortion Pill
• Ex-HHS Head Says Menendez Called Medicare Policy 'Unfair'
• 11th Circ. Revives Fla. Inmate's Lawsuit Over Delayed Meds
• Novartis, Genentech Want 'Hopeless' Kickback Suit Tossed
• Hundreds Of Mass. Hospital's Nurses Stage 1-Day Strike
• Fla. Can't Enforce Abortion Law That Violates Free Speech
• FBI Agent Testifies About Search In $1B Health Fraud Case
• Covidien Can't Stop Ethicon's Surgical Device Sales
• FTC Accuses Health Product Cos. Of Ad And Billing Scams
• Trump Admin Delays Penalties For Drug Price Overcharges
• Sens. Still Working On Stabilizing Health Insurance Markets
• Quest Tests Are Trade Secrets In Med Mal Suit, Pa. Court Says
• Vets Want DOD Docs About Radiation Exposure At Crash Site
• Ambulance Co. Sued Over Collection Of Worker Biometric Info
• J&J, DePuy Ask 1st Circ. For Stay To Appeal FCA Ruling
• FTC Says ND Physician Group Merger Must Wait
• Judging A Book: Tunheim Reviews 'Miles Lord'
• A Shift In Accommodating Employee Medical Marijuana Use
• Inversion Rule Defeat May Impair Regulatory Process
• Menendez 'Hostile' Over Medicare Policy, Ex-Official Says
• Justices Won't Disturb Fla. Patient Arbitration Dispute
• Ex-Katten Atty Fights To Keep 5 Experts In Shkreli Trial
• 3 Pa. Attys Sanctioned Over Surgery Payment Class Action
• PharMerica Looks To Duck Last Claims In Kickback Suit
• Shire Hits Allergan With Antitrust Suit Over Dry Eye Drugs
• Feds Ask 1st Circ. To Revive Meningitis Outbreak Charges
• Technology Assisted Review Can Work For Small Cases
• Pharmacist In Meningitis Trial Says He Never Tried To Run
• Justices Won't Hear 6 False Claims Act Appeals
• Calif. City Can Block Tax-Delinquent Weed Shop, Panel Says
• High Court Turns Away Handful Of Employment Petitions
• Supreme Court Turns Down Trio Of Antitrust Appeals
• UPMC's Suit Against Atty Over Client Solicitation To Advance
• Pfizer Loses Bid To Stop Rebate Disclosures To Lawmakers
• Univ. Section 403(b) Retirement Plans: Litigation Update
• Law360 Sizes Up The Term To Come